Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) European Union - English - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance

FOCLIVIA SUSPENSION Canada - English - Health Canada

foclivia suspension

seqirus uk limited - haemagglutinin-strain a (h5n1) - suspension - 7.5mcg - haemagglutinin-strain a (h5n1) 7.5mcg - vaccines

FOCLIVIA SUSPENSION Canada - English - Health Canada

foclivia suspension

seqirus uk limited - haemagglutinin-strain a (h5n1) - suspension - 7.5mcg - haemagglutinin-strain a (h5n1) 7.5mcg - vaccines

Porcilis PCV ID Formulation:   Each 0.2 mL (dose) contains:   Porcine Circovirus Type 2 (ORF2)> 1436 AU AU-Antigenic Units Emulsion for Injection (ID) Philippines - English - FDA (Food And Drug Administration)

porcilis pcv id formulation: each 0.2 ml (dose) contains: porcine circovirus type 2 (orf2)> 1436 au au-antigenic units emulsion for injection (id)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) virus vaccine (vet.) - emulsion for injection (id) - formulation: each 0.2 ml (dose) contains: porcine circovirus type 2 (orf2)> 1436 au au-antigenic units

Porcilis PCV Formulation:  Each 2 mL (dose) contains: Porcine Circovirus (PCV) Type 2 ORF2 Subunit Antigen........ > 3720 AU      AU-Antigenic Units Emulsion for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis pcv formulation: each 2 ml (dose) contains: porcine circovirus (pcv) type 2 orf2 subunit antigen........ > 3720 au au-antigenic units emulsion for injection (im)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: porcine circovirus (pcv) type 2 orf2 subunit antigen........ > 3720 au au-antigenic units

Startvac European Union - English - EMA (European Medicines Agency)

startvac

laboratorios hipra s.a. - escherichia coli j5 inactivated, staphylococcus aureus (cp8) strain sp 140 inactivated, expressing slime-associated antigenic complex - immunologicals for bovidae - cattle (cows and heifers) - for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and the severity of the clinical signs of clinical mastitis caused by staphylococcus aureus, coliforms and coagulase-negative staphylococci.the full immunisation scheme induces immunity from approximately day 13 after the first injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).

Nobivac L4 Formulation:   Each 1 mL (dose) contains:   Leptospira interrogans serogroup Canicola serovar Portland-vere (Ca-12-000 Strain). ............>2200 U Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (IC-02-001 Strain)... >210 U Leptospira interrogans serogroup Australis serovar Bratislava (As-05-073 Strain).............................> 420 U Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (Gr-01-005 Strain) .....................> 350 U U-Enzyme-Linked Immunosorbent Assay (ELISA) Antigenic Mass Unit Suspension For Injection (SC) Philippines - English - FDA (Food And Drug Administration)

nobivac l4 formulation: each 1 ml (dose) contains: leptospira interrogans serogroup canicola serovar portland-vere (ca-12-000 strain). ............>2200 u leptospira interrogans serogroup icterohaemorrhagiae serovar copenhageni (ic-02-001 strain)... >210 u leptospira interrogans serogroup australis serovar bratislava (as-05-073 strain).............................> 420 u leptospira kirschneri serogroup grippotyphosa serovar dadas (gr-01-005 strain) .....................> 350 u u-enzyme-linked immunosorbent assay (elisa) antigenic mass unit suspension for injection (sc)

msd animal health (phils.), inc. - inactivated leptospira interrogans (ser. canicola, icterohaemorrhagiae, australis) , l. kirschneri ser. grippotyphosa vaccine (vet.) - suspension for injection (sc) - formulation: each 1 ml (dose) contains: leptospira interrogans serogroup canicola serovar portland-vere (ca-12-000 strain). ............>2200 u leptospira interrogans serogroup icterohaemorrhagiae serovar copenhageni (ic-02-001 strain)... >210 u leptospira interrogans serogroup australis serovar bratislava (as-05-073 strain).............................> 420 u leptospira kirschneri serogroup grippotyphosa serovar dadas (gr-01-005 strain) .....................> 350 u u-enzyme-linked immunosorbent assay (elisa) antigenic mass unit

Porcilis Porcoli DF Formulation:  Each 2 mL (dose) contains:  Escherichia coli F4ab (K88ab) Fimbrial Adhesin (K12 Strain) . Escherichia coli F4ac (K88ac) Fimbrial Adhesin (K12 Strain) Escherichia coli F5 (K99) Fimbrial Adhesin (K12 Strain) Escherichia coli F6 (987P) Fimbrial Adhesin (987P-5 Strain) Escherichia coli LT toxoid (K12 Strain) ..  U – Determinal antigenic mass by ELISA (Enzyme-Lunkei Immunosorbent Assay)  Processed under FDA Memorandum Circular 2021-001.  ≥ 400 U 120 U ≥ 400 U  ≥ 1000 U  > 320 ng Suspension for Injection  (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis porcoli df formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng suspension for injection (im)

msd animal health (phils.), inc. - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng

Canigen DH (A2) PPIL Formulation:   Each 1 mL (dose) contains:   Canine Distemper Virus (Laderle Strain) ............   103-4.9 CCID50 Canine Adenovirus Type 2 (Manhattan Strain) .....   104-6 CCID 50 Canine Parvovirus (CPV 780916 Strain) ............................. 105-6,8 CCID50 Canine Parainfluenza Virus (Manhattan Strain) .................   105-6.9 CCID 50 Leptospira interrogans ser. Canicola .................................... 4350-7330 U (antigenic mass)   ser. Icterohaemorrhagiae .............. 4250-6910 U (antigenic mass) CCID- Cell Culture Infective Dose U-ELISA Freeze-Dried Pellet for   Injection (SC) Philippines - English - FDA (Food And Drug Administration)

canigen dh (a2) ppil formulation: each 1 ml (dose) contains: canine distemper virus (laderle strain) ............ 103-4.9 ccid50 canine adenovirus type 2 (manhattan strain) ..... 104-6 ccid 50 canine parvovirus (cpv 780916 strain) ............................. 105-6,8 ccid50 canine parainfluenza virus (manhattan strain) ................. 105-6.9 ccid 50 leptospira interrogans ser. canicola .................................... 4350-7330 u (antigenic mass) ser. icterohaemorrhagiae .............. 4250-6910 u (antigenic mass) ccid- cell culture infective dose u-elisa freeze-dried pellet for injection (sc)

virbac philippines inc. - live attenuated canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. canicola , l. interrogans var. icterohaemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (sc) - formulation: each 1 ml (dose) contains: canine distemper virus (laderle strain) ............ 103-4.9 ccid50 canine adenovirus type 2 (manhattan strain) ..... 104-6 ccid 50 canine parvovirus (cpv 780916 strain) ............................. 105-6,8 ccid50 canine parainfluenza virus (manhattan strain) ................. 105-6.9 ccid 50 leptospira interrogans ser. canicola .................................... 4350-7330 u (antigenic mass) ser. icterohaemorrhagiae .............. 4250-6910 u (antigenic mass) ccid- cell culture infective dose u-elisa

Porcilis PCV M Hyo Formulation:  Each 1 mL (dose) contains:  Porcine Circovirus, Type 2 - Orf 2 (WT 2/1 Strain) Mesomycoplasma hyopneumoniae (J Strain) .  AU - Antigenic Unit  RPU – Relative Potency Unit  Processed under FDA Memorandum Circular 2021-001.  ≥ 1414 AU  ≥ 2.69 RPU Emulsion for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis pcv m hyo formulation: each 1 ml (dose) contains: porcine circovirus, type 2 - orf 2 (wt 2/1 strain) mesomycoplasma hyopneumoniae (j strain) . au - antigenic unit rpu – relative potency unit processed under fda memorandum circular 2021-001. ≥ 1414 au ≥ 2.69 rpu emulsion for injection (im)

msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) , mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 1 ml (dose) contains: porcine circovirus, type 2 - orf 2 (wt 2/1 strain) mesomycoplasma hyopneumoniae (j strain) . au - antigenic unit rpu – relative potency unit processed under fda memorandum circular 2021-001. ≥ 1414 au ≥ 2.69 rpu